Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 5 | 2023 | 95 | 2.100 |
Why?
|
| Humans | 50 | 2025 | 4931 | 1.480 |
Why?
|
| Health Status Disparities | 2 | 2021 | 69 | 1.290 |
Why?
|
| Male | 38 | 2025 | 2620 | 1.250 |
Why?
|
| United States | 17 | 2025 | 764 | 1.210 |
Why?
|
| Female | 38 | 2025 | 2964 | 1.200 |
Why?
|
| African Americans | 7 | 2015 | 256 | 1.160 |
Why?
|
| Adult | 28 | 2023 | 1402 | 1.160 |
Why?
|
| Pandemics | 3 | 2023 | 65 | 1.060 |
Why?
|
| Middle Aged | 26 | 2023 | 1544 | 0.950 |
Why?
|
| Food | 1 | 2023 | 6 | 0.860 |
Why?
|
| Adolescent | 17 | 2025 | 569 | 0.850 |
Why?
|
| Databases, Factual | 5 | 2020 | 60 | 0.840 |
Why?
|
| Nutrition Assessment | 1 | 2023 | 26 | 0.800 |
Why?
|
| Aged | 20 | 2023 | 1188 | 0.790 |
Why?
|
| Fatty Liver | 2 | 2021 | 52 | 0.790 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 8 | 0.770 |
Why?
|
| Young Adult | 9 | 2021 | 382 | 0.740 |
Why?
|
| Mexican Americans | 1 | 2021 | 12 | 0.730 |
Why?
|
| Stress, Psychological | 3 | 2025 | 41 | 0.670 |
Why?
|
| Driving Under the Influence | 1 | 2020 | 1 | 0.670 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 31 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 258 | 0.650 |
Why?
|
| Bicycling | 1 | 2019 | 3 | 0.650 |
Why?
|
| Injury Severity Score | 1 | 2019 | 6 | 0.650 |
Why?
|
| Neck Injuries | 1 | 2019 | 5 | 0.650 |
Why?
|
| Head Protective Devices | 1 | 2019 | 3 | 0.650 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 9 | 0.640 |
Why?
|
| Hospital Mortality | 2 | 2019 | 30 | 0.640 |
Why?
|
| Aged, 80 and over | 12 | 2016 | 407 | 0.600 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 170 | 0.540 |
Why?
|
| Pancreatitis | 2 | 2007 | 6 | 0.520 |
Why?
|
| Dementia, Vascular | 1 | 2016 | 3 | 0.500 |
Why?
|
| Risk Factors | 9 | 2025 | 593 | 0.500 |
Why?
|
| Inpatients | 1 | 2016 | 17 | 0.490 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 26 | 0.480 |
Why?
|
| Dementia | 1 | 2015 | 13 | 0.480 |
Why?
|
| Puberty | 2 | 2025 | 9 | 0.470 |
Why?
|
| Nutrition Surveys | 5 | 2021 | 47 | 0.470 |
Why?
|
| Treatment Outcome | 4 | 2020 | 402 | 0.450 |
Why?
|
| Substance-Related Disorders | 2 | 2025 | 62 | 0.430 |
Why?
|
| Prevalence | 5 | 2021 | 184 | 0.430 |
Why?
|
| Metabolic Syndrome | 2 | 2020 | 29 | 0.420 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 8 | 0.410 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2003 | 22 | 0.400 |
Why?
|
| Child | 9 | 2025 | 336 | 0.390 |
Why?
|
| Immunization | 2 | 2001 | 18 | 0.340 |
Why?
|
| Hospitalization | 4 | 2015 | 106 | 0.340 |
Why?
|
| Retrospective Studies | 7 | 2023 | 513 | 0.320 |
Why?
|
| Comorbidity | 3 | 2016 | 123 | 0.290 |
Why?
|
| Jaundice | 1 | 2007 | 3 | 0.290 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 5 | 0.290 |
Why?
|
| Healthcare Disparities | 2 | 2023 | 69 | 0.290 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 16 | 0.290 |
Why?
|
| Albuminuria | 2 | 2020 | 24 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 93 | 0.280 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 2 | 0.280 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 2 | 0.280 |
Why?
|
| Diarrhea | 1 | 2007 | 8 | 0.270 |
Why?
|
| Cross Infection | 1 | 2007 | 10 | 0.270 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 358 | 0.260 |
Why?
|
| Hepatitis C | 1 | 2006 | 15 | 0.260 |
Why?
|
| Health Surveys | 3 | 2017 | 55 | 0.250 |
Why?
|
| Underage Drinking | 1 | 2025 | 4 | 0.240 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 39 | 0.240 |
Why?
|
| Los Angeles | 6 | 2010 | 244 | 0.230 |
Why?
|
| Dyspepsia | 1 | 2004 | 2 | 0.220 |
Why?
|
| Neurosecretory Systems | 1 | 2024 | 6 | 0.220 |
Why?
|
| Cultural Diversity | 2 | 2019 | 12 | 0.220 |
Why?
|
| Regression Analysis | 2 | 2021 | 59 | 0.220 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2023 | 2 | 0.220 |
Why?
|
| Chronic Disease | 2 | 2023 | 135 | 0.220 |
Why?
|
| Sex Characteristics | 1 | 2024 | 24 | 0.220 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 9 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2023 | 26 | 0.210 |
Why?
|
| Xylans | 2 | 2016 | 30 | 0.210 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 28 | 0.210 |
Why?
|
| Granulomatous Mastitis | 1 | 2023 | 1 | 0.210 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 12 | 0.210 |
Why?
|
| Exercise | 1 | 2023 | 41 | 0.200 |
Why?
|
| Eating | 1 | 2023 | 28 | 0.200 |
Why?
|
| Child, Preschool | 8 | 2013 | 177 | 0.200 |
Why?
|
| Veterans | 1 | 2023 | 61 | 0.200 |
Why?
|
| Population Surveillance | 3 | 2017 | 24 | 0.200 |
Why?
|
| Minority Groups | 2 | 2019 | 53 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2019 | 17 | 0.180 |
Why?
|
| Mentoring | 1 | 2021 | 12 | 0.180 |
Why?
|
| Small-Area Analysis | 1 | 2001 | 4 | 0.180 |
Why?
|
| Curcumin | 1 | 2020 | 5 | 0.180 |
Why?
|
| Physicians | 1 | 2021 | 37 | 0.180 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 9 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 28 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 23 | 0.170 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 15 | 0.170 |
Why?
|
| Depression | 2 | 2016 | 97 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 179 | 0.170 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 51 | 0.170 |
Why?
|
| Blood Alcohol Content | 1 | 2020 | 1 | 0.170 |
Why?
|
| Biomarkers | 3 | 2020 | 160 | 0.170 |
Why?
|
| Age Distribution | 1 | 2020 | 33 | 0.170 |
Why?
|
| Trauma Centers | 1 | 2019 | 6 | 0.160 |
Why?
|
| Education | 1 | 2019 | 10 | 0.160 |
Why?
|
| Research Personnel | 1 | 2019 | 8 | 0.160 |
Why?
|
| Sex Distribution | 2 | 2017 | 35 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 54 | 0.160 |
Why?
|
| Urological Agents | 1 | 2019 | 1 | 0.160 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 13 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 2 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 12 | 0.140 |
Why?
|
| Cognition | 1 | 2017 | 23 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2017 | 63 | 0.140 |
Why?
|
| Viremia | 1 | 2016 | 5 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 4 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2016 | 10 | 0.130 |
Why?
|
| Acute Disease | 2 | 2007 | 23 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2014 | 67 | 0.120 |
Why?
|
| Stroke | 1 | 2016 | 41 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2023 | 70 | 0.120 |
Why?
|
| Research Design | 3 | 2023 | 32 | 0.120 |
Why?
|
| Adolescent Development | 2 | 2025 | 10 | 0.120 |
Why?
|
| Sex Factors | 2 | 2025 | 120 | 0.110 |
Why?
|
| Hypertension | 1 | 2016 | 123 | 0.110 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 1 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2014 | 2 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 2 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 3 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 5 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 49 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2013 | 9 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2014 | 38 | 0.110 |
Why?
|
| Health Literacy | 1 | 2014 | 35 | 0.110 |
Why?
|
| California | 5 | 2014 | 161 | 0.110 |
Why?
|
| Empathy | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hand Injuries | 1 | 1993 | 1 | 0.110 |
Why?
|
| Joint Dislocations | 1 | 1993 | 2 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 1993 | 21 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2003 | 8 | 0.100 |
Why?
|
| Infant | 5 | 2013 | 132 | 0.100 |
Why?
|
| Health Services Accessibility | 2 | 2011 | 124 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 46 | 0.100 |
Why?
|
| Triazoles | 1 | 2011 | 12 | 0.090 |
Why?
|
| Pyrazines | 1 | 2011 | 16 | 0.090 |
Why?
|
| Nicotine | 1 | 2012 | 91 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 26 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 33 | 0.090 |
Why?
|
| Sunburn | 1 | 2010 | 1 | 0.090 |
Why?
|
| Sunlight | 1 | 2010 | 1 | 0.090 |
Why?
|
| Parenting | 1 | 2010 | 13 | 0.090 |
Why?
|
| Age Factors | 2 | 2025 | 152 | 0.080 |
Why?
|
| Health Education | 1 | 2010 | 46 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 51 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2007 | 19 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 159 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2023 | 229 | 0.080 |
Why?
|
| Brucellosis | 1 | 1988 | 1 | 0.080 |
Why?
|
| Muscular Diseases | 1 | 1988 | 3 | 0.080 |
Why?
|
| Bone Diseases | 1 | 1988 | 7 | 0.080 |
Why?
|
| Liver | 2 | 2023 | 139 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 404 | 0.070 |
Why?
|
| Pregnancy | 2 | 2006 | 417 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2007 | 4 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 6 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 8 | 0.070 |
Why?
|
| Focus Groups | 2 | 2019 | 33 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 45 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2021 | 31 | 0.070 |
Why?
|
| Telephone | 2 | 2010 | 3 | 0.070 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 2 | 0.070 |
Why?
|
| Colonic Diseases | 1 | 2006 | 3 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 2007 | 29 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 9 | 0.070 |
Why?
|
| Colon | 1 | 2006 | 16 | 0.070 |
Why?
|
| Adolescent Health Services | 1 | 2006 | 5 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2006 | 13 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 23 | 0.060 |
Why?
|
| Child Health Services | 1 | 2006 | 15 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2006 | 37 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 127 | 0.060 |
Why?
|
| HIV Infections | 1 | 2007 | 167 | 0.060 |
Why?
|
| Inflammation | 1 | 2006 | 122 | 0.060 |
Why?
|
| Testosterone | 1 | 2025 | 43 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2025 | 19 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 92 | 0.060 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Public Housing | 1 | 2005 | 6 | 0.060 |
Why?
|
| Marijuana Use | 1 | 2025 | 5 | 0.060 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 2 | 0.060 |
Why?
|
| Gallstones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 10 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 24 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 7 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 6 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 6 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 16 | 0.060 |
Why?
|
| ROC Curve | 1 | 2023 | 24 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 23 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2023 | 24 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 18 | 0.050 |
Why?
|
| Food Supply | 1 | 2023 | 11 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 58 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 51 | 0.050 |
Why?
|
| Urban Population | 1 | 2003 | 64 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 146 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 139 | 0.050 |
Why?
|
| Faculty | 1 | 2021 | 10 | 0.050 |
Why?
|
| Mentors | 1 | 2021 | 14 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2001 | 10 | 0.040 |
Why?
|
| Sirolimus | 1 | 2020 | 5 | 0.040 |
Why?
|
| Base Sequence | 1 | 2020 | 35 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 13 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 21 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 28 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 19 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2001 | 50 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 8 | 0.040 |
Why?
|
| Logistic Models | 1 | 2001 | 117 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 104 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2000 | 4 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2000 | 8 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 93 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 137 | 0.040 |
Why?
|
| Vaccines | 1 | 2000 | 8 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 62 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2020 | 35 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 101 | 0.040 |
Why?
|
| Vaccination | 1 | 2000 | 34 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 162 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2013 | 121 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 162 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 9 | 0.040 |
Why?
|
| Cause of Death | 1 | 2017 | 73 | 0.030 |
Why?
|
| Ribavirin | 1 | 2016 | 2 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 11 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 22 | 0.030 |
Why?
|
| Oryza | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 40 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 3 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 44 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 34 | 0.030 |
Why?
|
| England | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hospitals, District | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hospitals, General | 1 | 1993 | 1 | 0.030 |
Why?
|
| Finger Injuries | 1 | 1993 | 2 | 0.030 |
Why?
|
| Psychometrics | 1 | 2013 | 10 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 141 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2013 | 16 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 106 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 9 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 10 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2012 | 16 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 21 | 0.020 |
Why?
|
| Animal Feed | 1 | 2012 | 10 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 45 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2012 | 80 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 92 | 0.020 |
Why?
|
| Interdisciplinary Studies | 1 | 2011 | 2 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 5 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 196 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 28 | 0.020 |
Why?
|
| Sitagliptin Phosphate | 1 | 2011 | 6 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 18 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 117 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 44 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 34 | 0.020 |
Why?
|
| Ethiodized Oil | 1 | 2010 | 2 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2010 | 2 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 3 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 4 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 8 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 12 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 33 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 555 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 81 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 11 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 53 | 0.020 |
Why?
|
| Ethanol | 1 | 2010 | 55 | 0.020 |
Why?
|
| Health Promotion | 1 | 2010 | 70 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 202 | 0.020 |
Why?
|
| Saudi Arabia | 1 | 1988 | 1 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 1369 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1988 | 5 | 0.020 |
Why?
|
| Recurrence | 1 | 1988 | 25 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 21 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2006 | 8 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2006 | 21 | 0.020 |
Why?
|
| Eyeglasses | 1 | 2006 | 8 | 0.020 |
Why?
|
| Data Collection | 1 | 2005 | 27 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 61 | 0.010 |
Why?
|